Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)

BACKGROUND: Much controversy exists about the optimal management of a patent ductus arteriosus (PDA) in preterm infants, especially in those born at a gestational age (GA) less than 28 weeks. No causal relationship has been proven between a (haemodynamically significant) PDA and neonatal complicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hundscheid, Tim, Onland, Wes, van Overmeire, Bart, Dijk, Peter, van Kaam, Anton H. L. C., Dijkman, Koen P., Kooi, Elisabeth M. W., Villamor, Eduardo, Kroon, André A., Visser, Remco, Vijlbrief, Daniel C., de Tollenaer, Susanne M., Cools, Filip, van Laere, David, Johansson, Anne-Britt, Hocq, Catheline, Zecic, Alexandra, Adang, Eddy, Donders, Rogier, de Vries, Willem, van Heijst, Arno F. J., de Boode, Willem P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090763/
https://www.ncbi.nlm.nih.gov/pubmed/30077184
http://dx.doi.org/10.1186/s12887-018-1215-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090763/
https://www.ncbi.nlm.nih.gov/pubmed/30077184
http://dx.doi.org/10.1186/s12887-018-1215-7

Ejemplares similares